Abstract
Background
Microinvasion (MI), defined as infiltration of the portal or hepatic vein or bile duct and intrahepatic metastasis are accurate indicators of a poor prognosis for mall hepatocellular carcinomas (HCC). A previous study showed that intraoperative ultrasound (IOUS) definition of MI-HCC had a high concordance with histological findings. Aim of this study is to evaluate overall survival and recurrence patterns of patients with MI-HCC submitted to hepatic resection (HR) or laparoscopic ablation therapies (LAT).
Methods
A total of 171 consecutive patients (78 h; 93 LAT) with single, small HCC (< 3 cm) with a MI pattern at IOUS examination were compared analyzing overall survival and recurrence patterns using univariate and multivariate analysis and weighting by propensity score.
Results
Overall recurrences were similar in the 2 groups (HR: 51 patients (65%); LAT: 66 patients (71%)). The rate of local tumor progression in the HR group was very low (5 pts; 6%) in comparison to LAT group (22 pts; 24%; p = 0.002). The overall survival curves of HR are significantly better than that of the LAT group (p = 0.0039). On the propensity score Cox model, overall mortality was predicted by the surgical treatment with a Hazard ratio 1.68 (1.08–2.623) (p = 0.022).
Conclusions
If technically feasible and in patients fit for surgery, HR with an adequate tumor margin should be preferred to LAT in patients with MI-HCC at IOUS evaluation, to eradicate MI features near the main nodule, which are relatively frequent even in small HCC (< 3 cm).
Similar content being viewed by others
Data availability
Data are collected in database which could be checked.
References
Chen ZH, Zhang XP, Wang H, Chai ZT, Sun JX, Guo WX, Shi J, Cheng SQ (2019) Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB 21:935–944
Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493
Ferrer-Fabrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M, Fondevila C, Garcia-Valdecasas JC, Bruix J, Fuster J (2016) Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. Hepatology 63:839–849
Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A (2016) Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 22:232–252
Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y (2012) Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 19:2027–2034
Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD (2010) Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol 52:880–888
Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D’Errico-Grgioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D (2011) Preoperative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol 54:300–305
Zhao J, Mao J, Li W (2019) Association of tumor grade with long-term survival in patients with hepatocellular carcinoma after liver transplantation. Transplant Proc 51:813–819
Shen J, Liu J, Li C, Wen T, Yan L, Yang J (2018) The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: a propensity score matching analysis. Dig Dis Sci 63:1962–1969
Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, Ikeda K, Kumada H, Watanabe G (2015) The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size. World J Surg 39:1134–1141
Iguchi T, Shirabe K, Aishima S, Wang H, Fujita N, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Oda Y, Maehara Y (2015) New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation. Transplantation 99:1236–1242
Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, Yang G, Yan X, Zhang YD, Liu XS (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144
Chen J, Zhou J, Kuang S, Zhang Y, Xie S, He B, Deng Y, Yang H, Shan Q, Wu J, Sirlin CB, Wang J (2019) Liver imaging reporting and data system category 5: MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR 213:821–830
Hu HT, Wang Z, Huang XW, Chen SL, Zheng X, Ruan SM, Xie XY, Lu MD, Yu J, Tian J, Liang P, Kuang M (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890–2901
Santambrogio R, Cigala C, Maggioni BM, M, Scifo G, Bruno S, Bertolini E, Opocher E, Bulfamante G, (2018) Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behavior: prospective comparison with pathology. Liver Int 38:312–320
Santambrogio R, Barabino M, De Nicola E, Galfrascoli E, Giovenzana M, Zappa MA (2020) Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness? Surg Endosc 16:349–354
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314
Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB 15:78–84
Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R (1973) Transection of the esophagus for bleeding esophageal varices. Br J Surg 60:646–649
Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lock AS (2005) Prognosis of hepatocellular carcinoma: Comparison of seven staging systems in an American cohort. Hepatology 41:707–716
Santambrogio R, Costa M, Strada D, Bertolini E, Zuin M, Barabino M, Opocher E (2011) Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments. Ultrasound Med Biol 37:7–15
Santambrogio R, Bruno S, Kluger CM, Salceda J, Belli A, Laurent A, Barabino M, Opocher E, Azoulay D, Cherqui D (2016) Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis 48:189–196
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 633 patients and results of a survey. Ann Surg 240:205–213
Ahmed M (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273:241–260
Hajage D, Chauvet G, Belin L, Lafourcade A, Tubach F, De Rycke Y (2018) Closed-form variance estimator for weighted propensity score estimators with survival outcome. Biom J 60:1151–1163
Dong YI, Zhou L, Xia W, Zhao XY, Zhang Q, Jian JM, Gao X, Wang WP (2020) Preoperative prediction of microvascular invasion in hepatocellular carcinoma: initial application of a radiomic algorithm based on grayscale ultrasound images. Front Oncol 10:353. https://doi.org/10.3389/fonc.2020.00353
Zhu YJ, Feng B, Wang S, Wang LM, Wu JF, Ma XH, Zhao XM (2019) Model-based three-dimensional texture analysis of contrast-enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Oncol Let 18:720–732
Wang H, Wu MC, Cong WM (2019) Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis. Hepatol Res 49:344–354
Han J, Li ZL, Xing H, Wu H, Zhu P, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Wu MC, Shen F, Yang T (2019) The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB 21:962–971
Hidaka M, Eguchi S, Okuda K, Beppu T, Shirabe K, Kondo K, Takami Y, Ohta M, Shiraishi M, Ueno S, Nanashima A, Noritomi T, Kitahara K, Fujioka H (2020) Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1). A multi-institutional study by the Kyushu Group of Liver Surgery. Ann Surg 271:339–346
Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Kim SY, Sinn DH, Kim JM, Kim K, Sy Ha (2019) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. https://doi.org/10.1097/SLA.0000000000003268
Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M (2018) Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness? Cancers 10:378. https://doi.org/10.3390/cancers10100378
Rossi S, Ravetta V, Rosa L, Ghittoni G, Torello Viera F, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P, Tinelli C (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study 53:136–147
Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI (2014) Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–909
Sparchez Z, Mocan T, Radu P, Mocan LP, Sparchez M, Leucuta DC, Al HN (2018) Prognostic factors after percutaneous ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis 27:399–407
Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ (2005) Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 60:1018–1025
Santambrogio R, Salceda J, Costa M, Kluger MD, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D (2013) External validation of a simplified BCLC staging system for early hepatocellular carcinoma. EJSO 39:850–857
Cillo U, Bertacco A, Fasolo E, Carandina R, Vitale A, Zanus G, Gringeri E, D’Amico F, Bassi D, Neri D, Dadduzio V, Farinati F, Aliberti C (2019) Videolaparoscopic microwave ablation in patients with HCC at a European high-volume cnter: results of 815 procedures. J Surg Oncol 120:956–965
Vibert E, Schwartz M, Olthoff KM (2020) Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol 72:262–276
Fan H, Zhou C, Yan J, Meng W, Zhang W (2020) Treatment of solitary hepatocellular carcinoma up to 2 cm. A PRISMA-compliant systematic review and meta-analysis. Medicine 99:e20321. https://doi.org/10.1097/MD.0000000000020321
Funding
No funding.
Author information
Authors and Affiliations
Contributions
RS acts as the submission's guarantor. Each author participated with substantial contributions to conception, analysis and interpretation of data, active participate in drafting and revising it, with a final approval for publication. RS: project development, data analysis & collection, interpretation of data, manuscript writing/editing. MB: project development, data analysis & collection, interpretation of data, manuscript editing. VD’A: data analysis & collection, manuscript editing. GI: data analysis & collection, manuscript editing. EO: project development, interpretation of data, manuscript editing. MG: project development, interpretation of data, manuscript writing/editing. MAZ: project development, interpretation of data, manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest or financial ties to disclose.
Ethics approval
This retrospective study protocol was approved by our Institutional Review Board and waived the requirement for informed consent.
Research involving human participants and/or animals Institutional review research board approval was granted by ASST Fatebenefratelli Sacco, and appropriate good clinical and research practices were followed.
Informed consent
We have obtained consent to publish from the participants to report individual patient data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This paper has been accepted by the EAES Congress 2020 and it is eligible to be fast-tracked.
Rights and permissions
About this article
Cite this article
Santambrogio, R., Barabino, M., D’Alessandro, V. et al. Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?. Updates Surg 73, 1359–1369 (2021). https://doi.org/10.1007/s13304-021-01036-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-021-01036-0